More serious concerns, such as pancreatitis, changes in vision, and renal impairment, have been noted but occur less frequently
One week after discontinuing WEGOVY 2.4 mg injection, initiate 25 mg of WEGOVY tablets orally once daily
Patients should contact their clinician or pharmacist about persistent or severe symptoms
The two havent been tested head-to-head, so cross-trial comparisons should be read with care
After up to a year, the GLP-1 group showed significantly lower disease activity, less pain, improved cholesterol and HbA1c, and meaningful weight loss, with inflammatory markers (CRP and ESR) also improving
Resources on peptide safety and risks should be required reading for anyone in this situation